Inceptive
Inceptive is seeking a scientific leader to build and oversee an experimental platform that trains, tests, and improves foundation models of life for drug discovery. The role integrates molecular and cellular biology, functional genomics, high‑throughput screening, and automation, collaborating closely with machine learning and translational biology experts to generate model‑ready data and drive therapeutic design.
Headquarters
Palo Alto, California, United States
Company Size
11-50 employees
Founded
2021
Inceptive builds AI foundation models of life to design breakthrough biological medicines for humanity's most challenging diseases. Specializing in sequence-based medicines such as mRNA, siRNA, ASOs, and peptides, the company combines large-scale wet lab experimentation with deep learning to extrapolate novel drug candidates beyond existing data. Founded in 2021 by AI and biochemistry pioneers, Inceptive partners with leading drugmakers and operates offices in Palo Alto, Berlin, and Zurich.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Inceptive.
Scaling Experiments for AI-designed Medicines
a16z
Lead Researcher
St. Jude Children's Research Hospital
Immunology Senior Research Scientist - Single-Cell Genomics
Vertex
Postdoctoral Fellow, Single-Cell Method Development
Biohub
Visiting Research Assistant Professor in RNA Biology and Functional Genomics
Internal Job Board
Post-Doctoral Research Position in Surgical Sciences
UMB Bank